Guidelines for Using QuantiFERON-TB Gold Test in the United States
by Gerald H. Mazurek
Available on 1 platform
Sign in to view source links and access this dataset
Description
United States guidelines for the QuantiFERON-TB Gold test, a diagnostic tool approved by the FDA in May 2005. The report, authored by Gerald H. Mazurek, provides recommendations for using the test in contact investigations, immigrant evaluations, and healthcare worker surveillance. It details the test's mechanism, which detects interferon-gamma in response to specific M. tuberculosis antigens, and outlines cautions for interpreting results.
Use Cases
Developing clinical protocols for latent TB infection screening based on the described test applications.
Comparing diagnostic test performance (sensitivity/specificity) as discussed for QFT-G versus the tuberculin skin test.
Informing public health policy for TB control programs based on the specific recommendations and cautions provided.
Training laboratory personnel on the principles and interpretation of interferon-gamma release assays described in the report.
Strengths
Provides specific FDA approval date (May 2, 2005) and test manufacturer details.
Includes direct comparisons of test sensitivity with the established tuberculin skin test.
Offers concrete recommendations for use in defined scenarios like contact investigations.
Limitations
Description metadata is limited; actual data quality requires manual inspection after download.
Row count is unknown, which may limit suitability assessment.
Last update date is unknown; freshness unverified.
Provenance
Source
Gerald H. Mazurek, likely associated with the U.S. Centers for Disease Control and Prevention (CDC).
Collection Method
Report based on a July 2005 CDC-convened meeting of consultants and researchers.
Time Range
Focuses on evidence and recommendations circa 2005.